布地奈德混悬液和特布他林雾化吸入治疗哮喘性支气管炎的临床疗效  

Clinical efficacy of aerosol inhalation of budesonide suspension and terbutaline in the treatment of asthmatic bronchitis

作　　者：魏换影[1] Wei Huanying(Pingyu County People′s Hospital,Zhumadian,Henan,463400)

机构地区：[1]平舆县人民医院,河南驻马店463400

出　　处：《辽宁医学杂志》2024年第2期25-27,共3页Medical Journal of Liaoning

摘　　要：目的探讨布地奈德混悬液和特布他林雾化吸入治疗哮喘性支气管炎的临床疗效。方法回顾性选取我院2020年2月至2022年2月收治的108例哮喘性支气管炎患儿为研究对象,随机分为2组,即观察组54例与对照组54例,观察组患儿实施布地奈德混悬液和特布他林雾化吸入治疗,对照组患儿仅实施特布他林雾化吸入治疗。比较两组患者治后相关临床症状消失时间及疗效。结果观察组患儿治疗后临床总有效率98.14%(53例/54例)显著高于对照组临床总有效率85.19%46例/54例(χ^(2)=5.939,P=0.015);观察组患儿相关临床症状消失时间均短于对照组患儿(P<0.05)。结论哮喘性支气管炎患儿应用布地奈德混悬液和特布他林联合雾化吸入治疗临床效果显著,可有效缩短相关症状消失时间,促进恢复,值得推广。Objective To investigate the clinical efficacy of aerosol inhalation of budesonide suspension and terbutaline in the treatment of asthmatic bronchitis.Methods One hundred and eight children with asthmatic bronchitis admitted to our hospital from February 2020 to February 2022 were randomly divided into an observation group(n=54)and a control group(n=54).The observation group was treated with aerosol inhalation of budesonide suspension and terbutaline,while the control group was treated with aerosol inhalation of terbutaline only.The disappearance time and curative effect of related clinical symptoms after treatment were compared between the two groups.Results The overall response rate(ORR)of 98.14%(53/54)in the observation group was significantly higher than that of 85.19%(46/54)in the control group(χ^(2)=5.939,P=0.015),while the disappearance time of related clinical symptoms in the observation group was shorter than that in the control group(P<0.05).Conclusion Budesonide suspension combined with terbutaline atomization inhalation in the treatment of children with asthmatic bronchitis has a significant clinical effect,including effectively shortening the time of disappearance of related symptoms and promoting recovery.It is worthy of promotion.

关 键 词：布地奈德混悬液 特布他林 雾化吸入治疗 哮喘性支气管炎 

分 类 号：R725.6[医药卫生—儿科]